• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可逆性单泛素化调节帕金森病相关泛素水解酶UCH-L1。

Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.

作者信息

Meray Robin K, Lansbury Peter T

机构信息

Department of Neurology, Harvard Medical School and Brigham and Women's Hospital, Cambridge, Massachusetts 02139, USA.

出版信息

J Biol Chem. 2007 Apr 6;282(14):10567-75. doi: 10.1074/jbc.M611153200. Epub 2007 Jan 26.

DOI:10.1074/jbc.M611153200
PMID:17259170
Abstract

Deubiquitinating enzymes (DUBs) are negative regulators of protein ubiquitination and play an important role in ubiquitin-dependent processes. Recent studies have found that diverse cellular mechanisms are employed to control the activity of DUBs. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is a highly expressed neuronal DUB linked to Parkinson disease; however, little is known about its specific functions or modes of regulation. Here, we demonstrate that UCH-L1 is post-translationally modified by monoubiquitin in cells, at lysine residues near the active site. This modification restricts enzyme activity by preventing binding to ubiquitinated targets, and permanent monoubiquitination, as mimicked by a ubiquitin-UCH-L1 fusion, inhibits UCH-L1 in its capacity to increase free ubiquitin levels in cells. Interestingly, UCH-L1 catalyzes its own deubiquitination in an intramolecular manner, thereby regulating the lifetime of this modification. Our results illustrate monoubiquitination as a reversible regulatory mechanism for DUB activity involving auto-deubiquitination.

摘要

去泛素化酶(DUBs)是蛋白质泛素化的负调控因子,在泛素依赖性过程中发挥重要作用。最近的研究发现,多种细胞机制被用于控制DUBs的活性。泛素C末端水解酶-L1(UCH-L1)是一种与帕金森病相关的高表达神经元DUB;然而,对其具体功能或调控模式知之甚少。在这里,我们证明UCH-L1在细胞中在活性位点附近的赖氨酸残基处被单泛素进行翻译后修饰。这种修饰通过阻止与泛素化靶标的结合来限制酶活性,并且如泛素-UCH-L1融合所模拟的永久性单泛素化抑制UCH-L1增加细胞中游离泛素水平的能力。有趣的是,UCH-L1以分子内方式催化自身的去泛素化,从而调节这种修饰的寿命。我们的结果表明单泛素化是一种涉及自去泛素化的DUB活性的可逆调控机制。

相似文献

1
Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.可逆性单泛素化调节帕金森病相关泛素水解酶UCH-L1。
J Biol Chem. 2007 Apr 6;282(14):10567-75. doi: 10.1074/jbc.M611153200. Epub 2007 Jan 26.
2
Substrate recognition and catalysis by UCH-L1.泛素羧基末端水解酶L1对底物的识别与催化作用
Biochemistry. 2006 Dec 12;45(49):14717-25. doi: 10.1021/bi061406c.
3
Ubiquitin dimers control the hydrolase activity of UCH-L3.泛素二聚体控制UCH-L3的水解酶活性。
Neurochem Int. 2009 May-Jun;54(5-6):314-21. doi: 10.1016/j.neuint.2008.12.013. Epub 2008 Dec 25.
4
Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB.泛素C末端水解酶L1(UCH-L1)通过其对TrkB的去泛素化作用促进海马依赖性记忆。
J Neurosci. 2017 Jun 21;37(25):5978-5995. doi: 10.1523/JNEUROSCI.3148-16.2017. Epub 2017 May 12.
5
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron.泛素羧基末端水解酶L1在神经元中与单泛素结合并使其稳定。
Hum Mol Genet. 2003 Aug 15;12(16):1945-58. doi: 10.1093/hmg/ddg211.
6
The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons.泛素羧基末端水解酶L1(UCH-L1)的C末端在蛋白质稳定性中起关键作用,但在原代神经元中,其法尼基化对于膜结合并非必需。
J Biol Chem. 2014 Dec 26;289(52):36140-9. doi: 10.1074/jbc.M114.557124. Epub 2014 Oct 17.
7
Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.泛素羧基末端水解酶-L1通过调节由NADPH氧化酶4产生的过氧化氢来增加癌细胞的侵袭能力。
Oncotarget. 2015 Jun 30;6(18):16287-303. doi: 10.18632/oncotarget.3843.
8
UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.UCH-L1应激蛋白酶体损伤形成聚集体表明其在帕金森病包涵体形成中发挥作用。
J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x.
9
Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.帕金蛋白介导的K63多聚泛素化将泛素C末端水解酶L1作为靶点,通过自噬-溶酶体系统进行降解。
Cell Mol Life Sci. 2015 May;72(9):1811-24. doi: 10.1007/s00018-014-1781-2. Epub 2014 Nov 18.
10
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.膜相关的法尼基化泛素羧基末端水解酶L1促进α-突触核蛋白神经毒性,是帕金森病的治疗靶点。
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4635-40. doi: 10.1073/pnas.0806474106. Epub 2009 Mar 4.

引用本文的文献

1
Assessing the Suitability of Deubiquitylases As Substrates For Targeted Protein Degradation.评估去泛素化酶作为靶向蛋白质降解底物的适用性。
bioRxiv. 2025 Jun 14:2025.06.13.659525. doi: 10.1101/2025.06.13.659525.
2
Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia.与显性 UCHL1 突变相关的表型变异性:约三个伴有视神经萎缩和共济失调的家系。
J Neurol. 2024 Sep;271(9):6038-6044. doi: 10.1007/s00415-024-12574-z. Epub 2024 Jul 20.
3
Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease.
泛素羧基末端水解酶L1及其在帕金森病中的作用。
Int J Mol Sci. 2024 Jan 21;25(2):1303. doi: 10.3390/ijms25021303.
4
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2.细胞验证化学改良抑制剂鉴定 OTUB2 上的单泛素化。
ACS Chem Biol. 2023 Sep 15;18(9):2003-2013. doi: 10.1021/acschembio.3c00227. Epub 2023 Aug 29.
5
USP35 dimer prevents its degradation by E3 ligase CHIP through auto-deubiquitinating activity.USP35 二聚体通过自身去泛素化活性防止其被 E3 连接酶 CHIP 降解。
Cell Mol Life Sci. 2023 Apr 1;80(4):112. doi: 10.1007/s00018-023-04740-9.
6
Structural basis for specific inhibition of the deubiquitinase UCHL1.UCHL1 去泛素化酶特异性抑制的结构基础。
Nat Commun. 2022 Oct 10;13(1):5950. doi: 10.1038/s41467-022-33559-4.
7
Atypical Ubiquitination and Parkinson's Disease.非典型泛素化与帕金森病。
Int J Mol Sci. 2022 Mar 28;23(7):3705. doi: 10.3390/ijms23073705.
8
Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.去泛素化酶(DUBs):调控、动态平衡和氧化应激反应。
J Biol Chem. 2021 Sep;297(3):101077. doi: 10.1016/j.jbc.2021.101077. Epub 2021 Aug 12.
9
Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W.抗体工具包揭示了 UBE2W 的 N 端泛素化底物。
Nat Commun. 2021 Jul 29;12(1):4608. doi: 10.1038/s41467-021-24669-6.
10
Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.去泛素化酶的翻译后修饰:拓展泛素密码
Front Pharmacol. 2021 Jun 10;12:685011. doi: 10.3389/fphar.2021.685011. eCollection 2021.